Chengdu Olymvax Biopharmaceuticals Inc Sustainability Reports

Chengdu Olymvax Biopharmaceuticals Inc. researches, develops, manufactures, and sells human vaccines in China. Its product line includes adsorbed tetanus vaccines, Hib conjugate vaccines, and AC conjugate vaccines.

Sector: Manufacturing

Country: China

Exchange: Shanghai Stock Exchange

FIGI: BBG00CF6BDW7

3 reports from 2022 to 2024

• Chengdu Olymvax Biopharmaceuticals Inc 2024 Annual Report
• Chengdu Olymvax Biopharmaceuticals Inc 2023 Annual Report
• Chengdu Olymvax Biopharmaceuticals Inc 2022 Annual Report